|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 401/12 | (2006.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3999506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20743121.4 |
| Date of filing the European patent application | 2020-07-17 | |
| (97) | Date of publication of the European application | 2022-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-15 |
| (46) | Date of publication of the claims translation | 2025-04-10 |
| (86) | Number | PCT/EP2020/070306 |
| Date | 2020-07-17 |
| (87) | Number | WO 2021/013735 |
| Date | 2021-01-28 |
| (30) | Number | Date | Country code |
| 201962876065 P | 2019-07-19 | US |
| (72) |
PACKER, Martin, John , GB
JOHANNES, Jeffrey, Wallace , US
HANDE, Sudhir, Mahadeo , US
DEGORCE, Sebastien, Louis , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PARP1 inhibitoriai |
| PARP1 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-06-26 | 6 | 139.00 EUR |
| 2026-07-17 |